LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.69
-0.02 (-0.19%)
At close: Aug 21, 2026, 4:00 PM EDT
7.63
-0.06 (-0.78%)
After-hours: Aug 21, 2026, 7:30 PM EDT

LeonaBio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
21.2716.6826.0933.332.5521.23
Research & Development
33.517.570.6893.7961.4642.79
Operating Expenses
54.7734.1896.78127.0994.0264.02
Operating Income
-54.77-34.18-96.78-127.09-94.02-64.02
Other Non Operating Income (Expenses)
-18.92-3.673.456.387.969.17
EBT Excluding Unusual Items
-73.7-37.85-93.33-120.71-86.06-54.85
Gain (Loss) on Sale of Investments
0.330.330.521.410.42-
Legal Settlements
---4.13--10-
Pretax Income
-141.46-105.61-96.94-117.67-95.64-54.85
Net Income
-141.46-105.61-96.94-117.67-95.64-54.85
Net Income to Common
-141.46-105.61-96.94-117.67-95.64-54.85
Net Income Growth
------
Shares Outstanding (Basic)
1344444
Shares Outstanding (Diluted)
1344444
Shares Change
233.81%11.12%1.21%0.76%2.20%208.53%
EPS (Basic)
-10.88-24.70-25.19-30.95-25.35-14.86
EPS (Diluted)
-10.88-24.70-25.19-30.95-25.35-14.86
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.93-45.73-97.2-101.06-73.61-44.67
Free Cash Flow Per Share
-4.76-10.70-25.26-26.58-19.51-12.10
EBITDA
-53.83-33.21-95.81-126.13-93.17-63.54
D&A For EBITDA
0.940.970.970.970.850.48
EBIT
-54.77-34.18-96.78-127.09-94.02-64.02
SEC Filings: 10-K · 10-Q